Skip to content

Clinical trials

Phase 2 Atrial Fibrillation trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrial Fibrillation Phase: Phase 2 Country / region: Germany Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20053
20071
20082
20092
20101
20112
20122
20131
20141
20201
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting4
Terminated4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer2
GlaxoSmithKline2
Novartis Pharmaceuticals2
Abbott Medical Devices1
Acesion Pharma1
Advanz Pharma1
Astellas Pharma Inc1
AstraZeneca1
Biosense Webster, Inc.1
C. R. Bard1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation20
Arrhythmias, Cardiac4
Atrial Flutter3
Stroke2
Cardiovascular Diseases1
Heart Diseases1
Ischemic Attack, Transient1
Pathologic Processes1
Thromboembolism1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.